Advertisement

Antigen Recognition and Autoimmunity

  • F. Sinigaglia
  • J. Hammer
Part of the Topics in Neuroscience book series (TOPNEURO)

Abstract

The genes for the human leukocyte antigen (HLA) class II molecules lie within the major histocompatibility complex (MHC) on chromosome 6. The HLA class II loci are clustered into three regions, known as DR, DQ and DP. Each of these regions contains at least one α gene and one ß gene. The gene products form an αß heterodimer which is expressed as a membrane-bound protein on the cell surface. HLA class II proteins play a central role in T-cell selection and activation. They bind peptide fragments derived from protein antigens and display them on the cell surface for interaction with the antigen-specific receptors of T lymphocytes.

Keywords

Human Leukocyte Antigen Major Histocompatibility Complex Class Myelin Basic Protein Human Leukocyte Antigen Class Experimental Allergic Encephalomyelitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brown JH, Jardetzky TS, Gorga JC et al. (1993) 3-Dimensional structure of the human class-II histocompatibility antigen HLA-DR1. Nature 364: 33–39PubMedCrossRefGoogle Scholar
  2. 2.
    Stern LJ, Brown JH, Jardetzky TS et al. (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368: 215–221PubMedCrossRefGoogle Scholar
  3. 3.
    Ghosh P, Amaya M, Mellins E, Wiley DC (1995) The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378: 457–462PubMedCrossRefGoogle Scholar
  4. 4.
    Hammer J, Takacs B, Sinigaglia F (1992) Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J Exp Med 176: 1007–1013PubMedCrossRefGoogle Scholar
  5. 5.
    Hammer J, Valsasnini P, Tolba K et al. (1993) Promiscuous and allele-specific anchors in HLA-DR binding peptides. Cell 74: 197–203PubMedCrossRefGoogle Scholar
  6. 6.
    Rudensky AY, Preston-Hurlburt P, Hong SC et al. (1991) Sequence analysis of peptides bound to MHC class II molecules. Nature 353: 622–627PubMedCrossRefGoogle Scholar
  7. 7.
    Hunt DF, Michel H, Dickinson TA et al. (1992) Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science 256:1817–1820PubMedCrossRefGoogle Scholar
  8. 8.
    Chicz RM, Urban RG, Gorga JC et al. (1993) Specificity and promiscuity among naturally processed peptides bound to HLA-DR Alleles. J Exp Med 178: 27–47PubMedCrossRefGoogle Scholar
  9. 9.
    Rammensee H-G, Friede T, Stevanovic S (1995) MHC ligands and peptide motifs: First listing. Immunogenetics 41: 178–228PubMedCrossRefGoogle Scholar
  10. 10.
    Boehncke W-H, Takeshita T, Pendleton CD et al. (1993) The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition. J Immunol 150: 331–341PubMedGoogle Scholar
  11. 11.
    Hammer J, Bono E, Gallazzi F et al. (1994) Precise prediction of major histocompatibility complex class II peptide interaction based on peptide side chain scanning. J Exp Med 180: 2353–2358PubMedCrossRefGoogle Scholar
  12. 12.
    Rammensee H-G (1993) Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 11: 213–244PubMedCrossRefGoogle Scholar
  13. 13.
    Sinigaglia F, Hammer J (1994) Defining rules for the peptide-MHC Class II interaction. Curr Opin Immunol 6: 52–56PubMedCrossRefGoogle Scholar
  14. 14.
    Hammer J (1995) New methods to predict MHC-binding sequences within protein antigens. Curr Opin Immunol 7: 263–269PubMedCrossRefGoogle Scholar
  15. 15.
    Hammer J, Sturniolo T, Sinigaglia F (1997) HLA class II peptide binding specificity and autoimmunity. Adv Immunol 66: 67–100PubMedCrossRefGoogle Scholar
  16. 16.
    Davies JL, Kawaguchi Y, Bennett ST et al. (1994) A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371:130–136PubMedCrossRefGoogle Scholar
  17. 17.
    Campbell RD, Trowsdale J (1994) Map of the human MHC. Immunol Today 14:349–352CrossRefGoogle Scholar
  18. 18.
    Nepom GT, Erlich HA (1991) MHC class II molecules and autoimmunity. Annu Rev Immunol 9: 493–520PubMedCrossRefGoogle Scholar
  19. 19.
    Todd JA, Acha-Orbea H, Bell JI et al. (1988) A molecular basis for MHC class II-associated autoimmunity. Science 240: 1003–1009PubMedCrossRefGoogle Scholar
  20. 20.
    Thorsby E (1995) HLA-associated disease susceptibility — Which genes are primarily involved? Immunologist 3: 51–58Google Scholar
  21. 21.
    Kappler J, Roehm N, Marrack P (1987) T cell tolerance by clonal elimination in the thymus. Cell 49: 273–280PubMedCrossRefGoogle Scholar
  22. 22.
    Roy S, Scherer MT, Briner TJ et al. (1989) Murine MHC polymorphism and T cell specificities. Science 244: 572–575PubMedCrossRefGoogle Scholar
  23. 23.
    Teh HS, Kisielow P, Scott B et al. (1988) Thymic major histocompatibility complex antigens and the ab T-cell receptor determine the CD4/CD8 phenotype of T cells. Nature 335: 229–233PubMedCrossRefGoogle Scholar
  24. 24.
    Tiwari JL, Terasaki PI (1985) HLA and disease associations. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  25. 25.
    Winchester R (1994) The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol 56: 289–466Google Scholar
  26. 26.
    Otha N, Nishimura YK, Tanimoto T et al. (1982) Association between HLA and Japanese patients with rheumatoid arthritis. Hum Immunol 5:123–132CrossRefGoogle Scholar
  27. 27.
    Gregersen PK, Shen M, Song QL et al. (1986) Molecular diversity of HLA-DR4 haplotaypes. Proc Natl Acad Sci USA 83: 2642–2646PubMedCrossRefGoogle Scholar
  28. 28.
    Nepom GT, Byers P, Seyfried C et al. (1989) HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotides probes. Arthritis Rheum 32:15–21PubMedCrossRefGoogle Scholar
  29. 29.
    Wordsworth BP, Lanchbury JS, Sakkas LI et al. (1989) HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci USA 86: 10049–10053PubMedCrossRefGoogle Scholar
  30. 30.
    Hammer J, Gallazzi F, Bono E et al. (1995) Peptide binding specificity of HLA-DR4 molecules: Correlation with rheumatoid arthritis association. J Exp Med 181: 1847–1855PubMedCrossRefGoogle Scholar
  31. 31.
    Holmdal R, Andersson M, Goldschmidt K et al. (1990) Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev 118: 193–232CrossRefGoogle Scholar
  32. 32.
    Mikecz K, Glant TT, Poole AR (1987) Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum 30: 306–318PubMedCrossRefGoogle Scholar
  33. 33.
    Gaston JSH, Life PF, Jenner PJ, Colston MJ, Bacon PA (1990) Recognition of a Mycobacteria-specific epitope in the 65-kD heat-shock protein by synovial fluid-derived T cell clones. J Exp Med 171: 831–841PubMedCrossRefGoogle Scholar
  34. 34.
    Fugger L, Rothbard J, Sonderstrup-McDevitt G (1996) Specificity of an HLA-DRB1*0401 restricted T cell response to type II collagen. Eur J Immunol 26: 928–933PubMedCrossRefGoogle Scholar
  35. 35.
    Marrosu MG, Muntoni F, Murru MR et al. (1988) Sardinian multiple sclerosis is associated with HLA-DR4: A serologic and molecular analysis. Neurology 348: 1749–1753CrossRefGoogle Scholar
  36. 36.
    Yacub BA, Daif AK (1988) Multiple sclerosis in Saudi Arabia. Neurology 328: 621–625CrossRefGoogle Scholar
  37. 37.
    Pettinelli CB, Fritz RB, Chou CHJ, McFarlin DEJ (1982) Encephalitogenic activity of guinea pig myelin basic protein in the SJL mouse. Immunology 129: 1209–1211Google Scholar
  38. 38.
    Fritz RB, Chou CHJ, McFarlin DE (1983) Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. J Immunol 130: 1024–1026PubMedGoogle Scholar
  39. 39.
    Enddoh M, Tabira T, Kunishita T et al. (1986) A proteolipid apoprotein is an encephalitogen of acute and relapsing autoimmune encephalomyelitis in mice. J Immunol 137: 3832–3835Google Scholar
  40. 40.
    Martin R, Jaraquemada D, Flerlage M et al. (1990) Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J Immunol 145: 540–548PubMedGoogle Scholar
  41. 41.
    Ota K, Matsui M, Milford E et al. (1990) T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis. Nature 346:183–187PubMedCrossRefGoogle Scholar
  42. 42.
    Pette M, Fujita K, Wilkinson D et al. (1990) Myelin autoreactivity in multiple sclerosis: Recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. Proc Natl Acad Sci USA 87: 7968–7972PubMedCrossRefGoogle Scholar
  43. 43.
    Zhang J, Markovic-Plese S, Lacet B et al. (1994) Increased frequency of interleukin 2-responsive T cell specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 179: 973–984PubMedCrossRefGoogle Scholar
  44. 44.
    Wucherpfennig KW, Sette A, Southwood S et al. (1994) Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J Exp Med 179: 279–290PubMedCrossRefGoogle Scholar
  45. 45.
    Valli A, Sette A, Kappos L et al. (1993) Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest 91: 616–628PubMedCrossRefGoogle Scholar
  46. 46.
    Vogt AB, Kropshofer H, Kalbacher H et al. (1994) Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. J Immunol 153: 1665–1673PubMedGoogle Scholar
  47. 47.
    Markovic-Plese S, Fukaura H, Zhang J et al. (1995) T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J Immunol 155: 982–992PubMedGoogle Scholar
  48. 48.
    Ito K, Bian H-J, Molina M et al. (1996) HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice susceptible to experimental allergic encephalomyelitis. J Exp Med 183: 2635–2644PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1999

Authors and Affiliations

  • F. Sinigaglia
    • 1
  • J. Hammer
    • 2
  1. 1.Roche Milano RicercheMilanItaly
  2. 2.Hoffmann-La-Roche Inc.Preclinical R&DNutleyUSA

Personalised recommendations